Debbie Avant

859 total citations
16 papers, 607 citations indexed

About

Debbie Avant is a scholar working on Pediatrics, Perinatology and Child Health, Economics and Econometrics and General Health Professions. According to data from OpenAlex, Debbie Avant has authored 16 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pediatrics, Perinatology and Child Health, 7 papers in Economics and Econometrics and 4 papers in General Health Professions. Recurrent topics in Debbie Avant's work include Pharmaceutical studies and practices (15 papers), Pharmaceutical Economics and Policy (7 papers) and Pediatric Pain Management Techniques (5 papers). Debbie Avant is often cited by papers focused on Pharmaceutical studies and practices (15 papers), Pharmaceutical Economics and Policy (7 papers) and Pediatric Pain Management Techniques (5 papers). Debbie Avant collaborates with scholars based in United States, Canada and Thailand. Debbie Avant's co-authors include William Rodriguez, M. Dianne Murphy, Lisa L. Mathis, Rosemary Roberts, Robert M. Califf, Jennifer S. Li, Daniel K. Benjamin, P. Brian Smith, Nidhi Tripathi and Reese H. Clark and has published in prestigious journals such as JAMA, PEDIATRICS and Clinical Pharmacology & Therapeutics.

In The Last Decade

Debbie Avant

15 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Debbie Avant United States	11	489	175	94	86	64	16	607
M. Dianne Murphy United States	14	426 0.9×	232 1.3×	74 0.8×	32 0.4×	42 0.7×	19	646
Lisa L. Mathis United States	7	245 0.5×	107 0.6×	46 0.5×	27 0.3×	27 0.4×	9	341
Kim A Bird United Kingdom	5	294 0.6×	59 0.3×	37 0.4×	59 0.7×	28 0.4×	5	423
Nazleen F. Khan United States	12	93 0.2×	134 0.8×	59 0.6×	20 0.2×	30 0.5×	18	529
Arsenio H.P. Paes Netherlands	10	82 0.2×	102 0.6×	51 0.5×	37 0.4×	26 0.4×	14	830
Synnöve Lindemalm Sweden	15	211 0.4×	33 0.2×	58 0.6×	24 0.3×	20 0.3×	32	507
Angeline M. Carlson United States	14	119 0.2×	74 0.4×	70 0.7×	17 0.2×	20 0.3×	38	648
G Vincze Switzerland	9	84 0.2×	187 1.1×	83 0.9×	23 0.3×	16 0.3×	23	944
Ruairi M Gallagher United Kingdom	4	164 0.3×	54 0.3×	20 0.2×	42 0.5×	20 0.3×	5	371
J. Daniel Robinson United States	9	85 0.2×	22 0.1×	50 0.5×	48 0.6×	34 0.5×	38	384

Countries citing papers authored by Debbie Avant

Since Specialization

Citations

This map shows the geographic impact of Debbie Avant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debbie Avant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debbie Avant more than expected).

Fields of papers citing papers by Debbie Avant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debbie Avant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debbie Avant. The network helps show where Debbie Avant may publish in the future.

Co-authorship network of co-authors of Debbie Avant

This figure shows the co-authorship network connecting the top 25 collaborators of Debbie Avant. A scholar is included among the top collaborators of Debbie Avant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debbie Avant. Debbie Avant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Abdel‐Rahman, Susan M., Debbie Avant, & Gilbert J. Burckart. (2025). Access to Pediatric-Friendly Formulations at the Time of Pediatric Labeling and After Marketing. PEDIATRICS. 157(1).

Oshikoya, Kazeem A., Debbie Avant, Sara L. Van Driest, et al.. (2018). Serious Adverse Events Associated with Off-Label Use of Azithromycin or Fentanyl in Children in Intensive Care Units: A Retrospective Chart Review. Pediatric Drugs. 21(1). 47–58. 11 indexed citations

Zimmerman, Kanecia O., P. Brian Smith, Ann McMahon, et al.. (2018). Duration of Pediatric Clinical Trials Submitted to the US Food and Drug Administration. JAMA Pediatrics. 173(1). 60–60. 14 indexed citations

Watt, Kevin, Debbie Avant, Daniel K. Benjamin, et al.. (2017). Effect of renal function on antihypertensive drug safety and efficacy in children. Pediatric Nephrology. 33(1). 139–146. 3 indexed citations

Avant, Debbie, Gerri Baer, Alfred Sorbello, et al.. (2017). Neonatal Safety Information Reported to the FDA During Drug Development Studies. Therapeutic Innovation & Regulatory Science. 52(1). 100–108. 6 indexed citations

Wang, Jian, Andrea N. Edginton, Debbie Avant, & Gilbert J. Burckart. (2015). Predicting neonatal pharmacokinetics from prior data using population pharmacokinetic modeling. The Journal of Clinical Pharmacology. 55(10). 1175–1183. 16 indexed citations

Avant, Debbie, et al.. (2015). A Survey of Neonatal Pharmacokinetic and Pharmacodynamic Studies in Pediatric Drug Development. Clinical Pharmacology & Therapeutics. 98(3). 328–335. 25 indexed citations

Winiecki, Scott K., et al.. (2015). Pediatric registries at the Food and Drug Administration: design aspects that increase their likelihood of success. Pharmacoepidemiology and Drug Safety. 25(5). 602–605. 3 indexed citations

Murphy, M. Dianne, et al.. (2014). Impact of Pediatric Exclusivity on Drug Labeling and Demonstrations of Efficacy. PEDIATRICS. 134(2). e512–e518. 67 indexed citations

10.

Snyder, Kristen, Gregory H. Reaman, Debbie Avant, & Richard Pazdur. (2013). The impact of the written request process on drug development in childhood cancer. Pediatric Blood & Cancer. 60(4). 531–537. 11 indexed citations

11.

Laughon, Matthew M., Debbie Avant, Nidhi Tripathi, et al.. (2013). Drug Labeling and Exposure in Neonates. JAMA Pediatrics. 168(2). 130–130. 85 indexed citations

12.

Avant, Debbie. (2012). Pediatric Information in Drug Product Labeling. JAMA. 307(18). 1914–1914. 94 indexed citations

13.

Dunne, Julia, et al.. (2010). Globalization Facilitates Pediatric Drug Development in the 21 st Century. Drug Information Journal. 44(6). 757–765. 2 indexed citations

14.

Benjamin, Daniel K., P. Brian Smith, Meng Sun, et al.. (2009). Safety and Transparency of Pediatric Drug Trials. Archives of Pediatrics and Adolescent Medicine. 163(12). 1080–6. 50 indexed citations

15.

Rodriguez, William, Arzu Selen, Debbie Avant, et al.. (2008). Improving Pediatric Dosing Through Pediatric Initiatives: What We Have Learned. PEDIATRICS. 121(3). 530–539. 114 indexed citations

16.

Benjamin, Daniel K., M. Dianne Murphy, Rosemary Roberts, et al.. (2006). Peer-Reviewed Publication of Clinical Trials Completed for Pediatric Exclusivity. JAMA. 296(10). 1266–1266. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact